Amneal Pharmaceuticals (AMRX) EBITDA Margin Growth (5y) (2022 - 2026)
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) EBITDA Margin Growth (5y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 375.00 |
| Mar 31, 2026 | 1,031.00 |
| Dec 31, 2025 | 980.00 |
| Sep 30, 2025 | 850.00 |
| Jun 30, 2025 | 1,306.00 |
| Mar 31, 2025 | 284.00 |
| Dec 31, 2024 | 1,620.00 |
| Sep 30, 2024 | 4,232.00 |
| Jun 30, 2024 | 1,828.00 |
| Mar 31, 2024 | 1,952.00 |
| Dec 31, 2023 | -238.00 |
| Sep 30, 2023 | -345.00 |
| Jun 30, 2023 | 5,713.00 |
| Mar 31, 2023 | -1,692.00 |
| Dec 31, 2022 | -2,103.00 |
| Sep 30, 2022 | -2,279.00 |
| Jun 30, 2022 | -5,267.00 |